美国FDA叫停吉利德HIV复方药物临床试验

老虎资讯综合
Jun 10

6月10日。吉利德科学盘前跌超4%,公司表示美国食品药品监督管理局(FDA)已对其两种实验性HIV治疗药物的联合用药试验实施临床暂停。

吉利德称,FDA做出这一决定是因为部分接受联合用药的患者被发现CD4+T淋巴细胞水平降低。CD4+T细胞是人体免疫系统中的关键白细胞类型。被叫停的试验涉及GS-1720和GS-4182两种药物,其中包括两项中后期阶段试验以及三项早期阶段试验。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10